https://scholars.lib.ntu.edu.tw/handle/123456789/579653
標題: | Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up | 作者: | KUAN-YIN LIN Cheng C.-Y. Li C.-W. Yang C.-J. Tsai M.-S. Liu C.-E. Lee Y.-T. Tang H.-J. Wang N.-C. Lin T.-Y. Lee Y.-C. Lin S.-P. YU-SHAN HUANG Zhang J.-Y. Ko W.-C. Cheng S.-H. CHIEN-CHING HUNG Taiwan HIV Study Group |
公開日期: | 2017 | 出版社: | Public Library of Science | 卷: | 12 | 期: | 6 | 起(迄)頁: | e0179870 | 來源出版物: | PLoS ONE | 摘要: | Objectives The international and national HIV treatment guidelines in 2016 have focused on scaling up access to combination antiretroviral therapy (cART). We aimed to assess the trends and treatment outcomes of late cART initiation in Taiwan. Methods Between June 2012 and May 2016, we retrospectively included antiretroviral-naive HIV-positive adults who initiated cART. Late initiation was defined as when cART was initiated in patients with a CD4 count ?200 cells/mm3 or having experienced AIDS-defining illnesses. The treatment outcomes were assessed up to 6 months after starting cART.Results We included 3655 HIV-positive patients, and the majority of the patients were male (95.4%) with a median age of 31 years and initiated non-nucleoside reverse-transcriptase inhibitor-containing regimens (87.0%). The median CD4 count at cART initiation increased from 207 cells/mm3 in 2012 to 298 cells/mm3 in 2016, and the overall proportion of late cART initiation decreased from 49.1% in 2012 to 29.0% in 2016 (P for trend ?0.001). Late cART initiation mainly resulted from late presentation for HIV care and was associated with older age (per 1-year increase, adjusted odds ratio [AOR], 1.05; 95% CI, 1.04–1.06), HBsAg seropositivity (AOR, 1.31; 95% CI, 1.04–1.64), HIV care in central and southern Taiwan, initiating cART in earlier year, non-intravenous drug users (AOR, 1.96; 95% CI, 1.33–2.86), and negative hepatitis C serostatus (AOR, 1.47; 95% CI, 1.04–2.08). Compared with non-late initiators, late initiators had a higher rate of all-cause mortality (1.7% vs. 0.3%) and regimen modification due to virological failure (7.1% vs. 2.6%). The predicting factors of all-cause mortality were late cART initiation (adjusted hazard ratio [AHR], 5.40; 95% CI, 2.14–13.65) and older age (AHR, 1.06; 95% CI, 1.03–1.10). Conclusions While the proportion of late cART initiation decreased over time in Taiwan, late initiation remained in a substantial proportion of HIV-positive patients. The late initiators had higher risk for poor outcomes. The need for strategies to earlier detection of HIV infection and expediting cART initiation should be highlighted, especially among the older population. ? 2017 Lin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021650668&doi=10.1371%2fjournal.pone.0179870&partnerID=40&md5=446334cb608f007f2c9986b4e192a9ed https://scholars.lib.ntu.edu.tw/handle/123456789/579653 |
ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0179870 | SDG/關鍵字: | abacavir plus dolutegravir plus lamivudine; efavirenz; emtricitabine; hepatitis B surface antigen; rilpivirine; tenofovir; anti human immunodeficiency virus agent; RNA directed DNA polymerase inhibitor; adult; age; antiretroviral therapy; Article; CD4 lymphocyte count; cohort analysis; female; human; Human immunodeficiency virus infection; major clinical study; male; mortality rate; retrospective study; Taiwanese; trend study; virus load; combination drug therapy; HIV Infections; Taiwan; treatment outcome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Taiwan; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。